Centene Corp vs Schwab US Large Cap Growth ETF — how do they compare? Centene Corp trades at $66.33 (market cap $32.89B), while Schwab US Large Cap Growth ETF trades at $35.76. Which is the better fit depends on your goals.
| CNC | SCHG | |
|---|---|---|
Market Cap | $32.89B | — |
Sector | Health | Sector/Thematic |
52-Week High | $68.72 | $35.83 |
52-Week Low | $26.17 | $28.10 |
Enterprise Value | $21.93B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SCHG trades at $35.78, up 1.02% today, with a bullish technical signal from moving averages and strong trend strength (ADX). The ETF's low 0.04% expense ratio and concentrated exposure to AI-driven tech giants like Nvidia and Microsoft support growth potential, though key valuation metrics are unavailable. Recent news highlights institutional position adjustments and AI capital expenditure tailwinds.
Outlook remains positive due to AI growth catalysts and cost efficiency, but risks include high concentration in top holdings and sensitivity to tech sector volatility. Analyst sentiment is mixed, with some citing premium valuations as a concern for near-term performance.
Trailing returns across standard periods
Latest headlines on both assets
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →